Back to results
US 2025/0108102 A1Published application
Novel fragmented crs peptide exhibiting immune enhancement activity, and use thereof
AssigneeZymedi Co., Ltd.
InventorsSung Hoon KIM, Sang Bum KIM, Seongmin CHO, Ee Chan SONG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel fragmented CRS peptide exhibiting immune enhancement activity, and a use thereof, and, more specifically, to a novel peptide consisting of an amino acid sequence of SEQ ID NO: 2, and a use thereof as a vaccine adjuvant and a cancer therapeutic agent. A peptide disclosed in the present invention is a CRS fragment disclosed for the first time in the present specification and exhibits an anti-cancer activity and immune enhancement activity.
Claims19
A peptide consisting of the amino acid sequence of SEQ ID NO:
- 2 or an amino acid sequence showing 95% or more sequence homology thereto.
Dependencies are inferred from the claim text.